Valid Ghana · FDA Ghana

ETHAMATOL DISPERSIBLE TABLETS

ETHAMATOL

FDA/SD.255-123485 ETHAMATOL 100mg

What it does

Ethamatol is a medication used to relieve anxiety and tension. It helps calm the mind and body.

Commonly used for: anxiety, nervousness, tension

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/SD.255-123485
Registration date
2025-12-31
Expiry date
2031-05-01
Status
Valid
Active ingredient
ETHAMATOL
Dosage form
ETHAMATOL
Strength
100mg
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Macleuds Pharmaceuticals
Applicant / LTR
phlly pharmaceuticals
Country of origin
INDIA
Manufacturer location
Atlanta Arcade, Marol Church Rd, Bori Colony, Vijay Nagar Colony West, Marol, Andheri East, Mumbai, Maharashtra 400059, India

Source: Food and Drugs Authority · fetched 2026-05-08 08:00:34 · updated 2026-10-20 04:00:09

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About this medicine

Ethamatol is a medication used to relieve anxiety and tension. It helps calm the mind and body.

What it treats

  • anxiety
  • nervousness
  • tension

How it works

Ethamatol works by affecting chemicals in the brain that are involved in mood and anxiety.

Who it's for

Ethamatol is for adults experiencing anxiety or stress-related conditions.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: ethamatol

Ethamatol is a sedative and anxiolytic medication belonging to the class of thienodiazepines. It is primarily used for its calming effects, facilitating sedation and reducing anxiety in patients. Ethamatol is commonly administered in clinical settings for short-term management of anxiety disorders and insomnia. Its use may also extend to preoperative sedation.

Indications

  • Anxiety disorders
  • Insomnia
  • Preoperative sedation

Dosage

Children: Refer to the BNF for Children for accurate paediatric dosing information.

Adults: Refer to specific clinical guidelines and patient factors, as dosing may vary based on individual needs and clinical judgment.

Mechanism of action

Ethamatol acts as a positive allosteric modulator of the GABA-A receptor, enhancing the inhibitory effects of gamma-aminobutyric acid (GABA). This action increases the frequency of chloride channel opening, leading to hyperpolarization of neurons, which results in a sedative and anxiolytic effect.

Pharmacodynamics

The pharmacodynamics of ethamatol are characterized by its ability to decrease neuronal excitability, thereby producing sedation, muscle relaxation, and anxiolysis. The onset of action typically occurs within a short period after administration, contributing to its efficacy in acute anxiety and panic situations. The drug's effects are dose-dependent, with higher doses leading to increased sedation and potential respiratory depression.

Pharmacokinetics

Ethamatol is absorbed rapidly following oral administration, with peak plasma concentrations typically reached within one to two hours. It undergoes hepatic metabolism, primarily through cytochrome P450 enzymes, leading to various metabolites. The elimination half-life is generally short, ranging from a few hours, which supports its use for acute interventions. The drug is excreted mainly through the urine as metabolites, with minimal unchanged drug detected.

Contra-indications

  • Hypersensitivity to ethamatol or any of its components.
  • Severe liver impairment.
  • Acute porphyria.

Adverse effects

  • Drowsiness
  • Dizziness
  • Nausea
  • Vomiting
  • Allergic reactions
  • Hepatic dysfunction

Interactions

  • May enhance the sedative effects of central nervous system depressants.
  • Potential interaction with anticoagulants, increasing the risk of bleeding.

Precautions

  • Use with caution in patients with hepatic impairment.
  • Monitor for potential allergic reactions.
  • Caution advised in the elderly due to increased sensitivity.

Pregnancy

Use in pregnancy only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Not recommended during breastfeeding due to potential effects on the infant.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

  • Tablets
  • Injectable solution

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.